Literature DB >> 16215489

Computer-assisted laparoscopic repair of "upside-down" stomach with the Da Vinci system.

Chris Braumann1, Charalambos Menenakos, Jens C Rueckert, Joachim M Mueller, Christoph A Jacobi.   

Abstract

Recently introduced telerobotic surgical systems attempt to elude the inherent limitations of traditional laparoscopic surgery. Four patients (3 male, 1 female) with mixed hiatal and paraesophageal hernias with fixed intrathoracic partial or complete displacement of the stomach were operatively treated using the Da Vinci robotic system. Tissue dissection, hiatoplasty, and anterior hemifundoplication (Dor) were performed with the telerobotic system. There were no surgical complications. The system broke down in the fourth patient due to a software defect. Advantages were seen in terms of the intrathoracic dissection of displaced stomach through a narrow hiatus, intracorporeal suturing due to 6 degrees of freedom plus grasping. At the moment, lack of the appropriate robotic instruments for abdominal surgery as well as the enormous functional cost of the robotic system are considered to be the most significant current impediment to the adoption of robotic abdominal surgery. The continuous evolution and upgrade of the system is quite promising so far. Telerobotic-assisted hiatal hernia operation is feasible with many advantages compared with the traditional laparoscopic approach, especially during the dissection in the mediastinum in patients with intrathoracic stomach. A prospective, randomized trial will be performed later to evaluate the advantages and limitations of robotic compared with traditional laparoscopy. Technological evolution will perhaps diminish the current problems and the cost associated with robotic surgery.

Entities:  

Mesh:

Year:  2005        PMID: 16215489     DOI: 10.1097/01.sle.0000183254.81560.e8

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  7 in total

Review 1.  Laparoscopic and robot-assisted laparoscopic digestive surgery: Present and future directions.

Authors:  Juan C Rodríguez-Sanjuán; Marcos Gómez-Ruiz; Soledad Trugeda-Carrera; Carlos Manuel-Palazuelos; Antonio López-Useros; Manuel Gómez-Fleitas
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

2.  Early robotic experience with paraesophageal hernia repair and Nissen fundoplication: short-term outcomes.

Authors:  Ward J Dunnican; T Paul Singh; Gloria G Guptill; Michael G Doorly; Ashar Ata
Journal:  J Robot Surg       Date:  2008-03-29

3.  SAGES TAVAC safety and effectiveness analysis: da Vinci ® Surgical System (Intuitive Surgical, Sunnyvale, CA).

Authors:  Shawn Tsuda; Dmitry Oleynikov; Jon Gould; Dan Azagury; Bryan Sandler; Matthew Hutter; Sharona Ross; Eric Haas; Fred Brody; Richard Satava
Journal:  Surg Endosc       Date:  2015-07-24       Impact factor: 4.584

4.  Early operative outcomes and learning curve of robotic assisted giant paraesophageal hernia repair.

Authors:  Inderpal S Sarkaria; M Jawad Latif; Valentino J Bianco; Manjit S Bains; Valerie W Rusch; David R Jones; Nabil P Rizk
Journal:  Int J Med Robot       Date:  2016-02-29       Impact factor: 2.547

Review 5.  A systematic review of robot-assisted anti-reflux surgery to examine reporting standards.

Authors:  Marc M Huttman; Harry F Robertson; Alexander N Smith; Sarah E Biggs; Ffion Dewi; Lauren K Dixon; Emily N Kirkham; Conor S Jones; Jozel Ramirez; Darren L Scroggie; Benjamin E Zucker; Samir Pathak; Natalie S Blencowe
Journal:  J Robot Surg       Date:  2022-09-08

6.  Surgical treatment of gastroesophageal reflux disease and upside-down stomach using the Da Vinci robotic system. A prospective study.

Authors:  Jens Hartmann; Christoph A Jacobi; Charalambos Menenakos; Mahmoud Ismail; Chris Braumann
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

Review 7.  Telerobotic gastrointestinal surgery: phase 2--safety and efficacy.

Authors:  G H Ballantyne
Journal:  Surg Endosc       Date:  2007-02-08       Impact factor: 3.453

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.